Fundraising FoxYosemite — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Eureka Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based therapies to treat solid tumors and other cancers.
BiotechHealthtechEmeryville, US
Cheng Liu(Executive Officer, Director)in
BoardSandy Chau(Director)Hsing Kung(Director)Qiushi Fu(Director)Chih-Kai Cheng(Director)inMichael Cannon(Director)
Board seatReed Jobs· per SEC Form D · $20M raise · filed May 2023
Co-investorsAcorn Pacific VenturesCloudStone CapitalGP Capital
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.
BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US
Akira Matsuno(Co-Founder, President, CFO, COO)inDerek Jantz(Executive Officer)inCharles Gersbach(Co-Founder)inJohn McHutchison(CEO, Chairman of the Board)inDan McHugh(Co-Founder, Investor)inBlythe Sather(Executive Officer)in
Co-investorsDuke Capital PartnersHatteras Venture PartnersMission BiocapitalNew Enterprise Associates (NEA)Pappas CapitalRV Invest GmbH+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.